NCIt definition : A recombinant, humanized monoclonal antibody directed against CD22, a cell surface
glycoprotein present on mature B-cells and on many types of malignant B-cells. After
binding to CD22, epratuzumab's predominant antitumor activity appears to be mediated
through antibody-dependent cellular cytotoxicity (ADCC).;
UNII : 3062P60MH9;
CAS number : 205923-57-5; a href https://gsrs.ncats.nih.gov/ginas/app/beta/browse-substance?search 205923-57-5
alt lien vers site G-SRS target _blank img src /img/logos/logo_g-srs.png alt Logo
G-SRS /a ;